# Lion's Mane Mushroom: What the Evidence Actually Shows for Brain Health
Canonical: https://www.migaku.app/guides/lions-mane-brain-health-guide
Category: evidence
Summary: Lion's mane has promising animal data and a small number of human trials. This guide explains what the evidence shows, what it doesn't, and why standardisation of mushroom extracts matters.
Last reviewed: 2026-05-09
Reviewed by: Migaku Editorial Team
## Quick Answer

Lion's mane (*Hericium erinaceus*) contains compounds (hericenones, erinacines) that stimulate Nerve Growth Factor (NGF) synthesis in laboratory and animal studies. The human clinical evidence is limited to a small number of trials showing modest cognitive benefits. It is a genuinely interesting supplement for brain health but remains preliminary in humans.

---

## Active Compounds

Two compound classes are relevant:
- **Hericenones**: Found in the fruiting body; can cross the blood-brain barrier and stimulate NGF.
- **Erinacines**: Found in the mycelium; more potent NGF stimulators in vitro.

Products using fruiting body extract vs mycelium extract will have different active compound profiles. This distinction matters — most trials use fruiting body extract.

---

## NGF and Why It Matters

Nerve Growth Factor (NGF) supports the survival, growth, and maintenance of neurons, particularly in the hippocampus (memory) and cholinergic basal forebrain (attention, learning). NGF declines with age, and reduced NGF is associated with Alzheimer's disease progression.

**Important caveat**: Supplementing orally to raise NGF in the brain involves several biological steps (intestinal absorption → blood-brain barrier crossing → receptor activation). The pathway exists in animal models; human evidence is limited.

---

## Human Clinical Evidence

A 2009 RCT (n=30) in mild cognitive impairment showed 250 mg lion's mane (standardised extract) three times/day for 16 weeks improved cognitive function scores vs placebo, with scores declining when supplementation stopped.

A 2023 RCT (n=41) in adults aged 18–45 found 1,800 mg/day lion's mane extract for 28 days improved processing speed on cognitive testing.

Several smaller studies show trends for reduced depression and anxiety scores.

---

## Evidence Summary

| Outcome | Evidence Level | Notes |
|---|---|---|
| Mild cognitive impairment | Preliminary | 1 RCT; n=30 |
| Cognitive speed in young adults | Preliminary | 1 RCT; short duration |
| NGF stimulation in humans | Preliminary | No direct human brain NGF measurement |
| Alzheimer's prevention | Insufficient | No human trials; only mechanistic/animal data |
| Anxiety/depression | Preliminary | Mixed, very small trials |
| Nerve regeneration | Preliminary | Animal only |

---

## Extract Quality: The Mushroom Supplement Problem

The lion's mane supplement market has significant quality problems:
- Most US supplements use mycelium grown on grain; the final product may be predominantly grain starch rather than mushroom compounds.
- Fruiting body extracts have higher hericenone content.
- Look for: "fruiting body" on label, verified beta-glucan content (>20%), and ideally third-party testing.

---

## Dosage Reference

| Form | Dose | Notes |
|---|---|---|
| Fruiting body extract (standardised) | 500–1,000 mg/day | Most common in trials |
| Higher dose | 1,000–3,000 mg/day | Used in some cognitive trials |
| Mycelium-based products | Not comparable | Effective dose unclear without standardisation data |

---

## Safety Notes

- Generally well-tolerated; no significant adverse events in published trials.
- Case reports of allergic reactions exist — avoid if you have mushroom allergies.
- Not studied in pregnancy.
- No established drug interactions but minimal research; caution with immunosuppressants (theoretical immune-modulating effects).